In orthotopic PDAC models using immunocompetent mice, these authors demonstrated that the addition of the IL-2 circuit to the CAR T not only enhanced anti-tumor efficacy but specifically increased the infiltration of CAR T cells into the tumors, demonstrating the importance of cytokines in CAR T infiltration into solid tumors (46). Here, IL2 is linked to neoplasm.